Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-29T07:54:39.189Z Has data issue: false hasContentIssue false
  • English
  • Français

Prescribing psychotropic drugs for the elderly

Published online by Cambridge University Press:  02 January 2018

Alistair Burns  and
Robert Baldwin
Alistair Burns
Affiliation:
University of Manchester, Withington Hospital, West Didsbury, Manchester M20 8LR
Robert Baldwin
Affiliation:
York House, Manchester Royal Infirmary, Oxford Road, Manchester M13 9BX
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The pharmacological treatment of the elderly differs from that of younger patients, mainly because of altered pharmacokinetics and the higher proportion of patients with organic disorders. We deal here with dementia, delirium, affective disorder, late-life schizophrenia, sleep disturbance, and rapid tranquillisation.

Type
Research Article
Information
Advances in Psychiatric Treatment , Volume 1 , Issue 1 , September 1994 , pp. 23 - 31
Copyright
Copyright © The Royal College of Psychiatrists 1994 

References

Abou-Saleh, M. T. & Coppen, A. (1983) The prognosis of depression in old age: the case for lithium therapy. British Journal of Psychiatry, 143, 527–528.Google Scholar
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.Google Scholar
Baldwin, R. C. & Jolley, D. J. (1986) The prognosis of depression in old age. British Journal of Psychiatry, 149, 574–583.Google Scholar
Ball, C. J. (1992) The use of clozapine in older people. International Journal of Geriatric Psychiatry, 7, 689–692.Google Scholar
Burns, A. (1992) Treatment by physical methods, medication. Current Opinion in Psychiatry, 5, 567–570.Google Scholar
Burns, A. (1993) Treatment of non-cognitive features of dementia. In Treatment and Care in Old Age Psychiatry (eds Levy, R., Howard, R. & Burns, A.) pp. 37–48. Petersfield: Wrightson Biomedical.Google Scholar
Evans, M. E. (1993) Depression in elderly physically ill inpatients, a 12 month prospective study. International Journal of Geriatric Psychiatry, 8, 587–592.Google Scholar
Finch, E. J. L. & Katona, C. L. E. (1989) Lithium augmentation in the treatment of refractory depression in old age. International Journal of Geriatric Psychiatry, 4, 41–46.Google Scholar
Flint, A. J. (1992) The optimum duration of antidepressant treatment in the elderly. International Journal of Geriatric Psychiatry, 7, 617–619.Google Scholar
Howard, R. & Levy, R. (1992) Which factors affect treatment response in late paraphrenia. International Journal of Geriatric Psychiatry, 7, 667–672.Google Scholar
Jacoby, R. (1991) Manic illness. In Psychiatry in the Elderly (eds Jacoby, R. & Oppenheimer, C.) pp. 720–734. Oxford: Oxford University Press.Google Scholar
Katona, C. L. E. (1993) Optimising treatment for the elderly depressive, new antidepressants in the elderly. Journal of Psychopharmacology, 7 (suppl. 1), 131–134.Google Scholar
Koenig, H. G., Goli, V., Shelp, F. et al (1989) Antidepressant use in elderly medical inpatients, lessons from an attempted clinical trial. Journal of General Internal Medicine, 4, 498–505.Google Scholar
Levy, R. (1993) Is there life in the neuro-transmitter approach to the treatment of Alzheimer's disease? In Treatment and Care in Old Age Psychiatry (eds Levy, R., Howard, R. & Burns, A.) pp. 39–46. Petersfield: Wrightson Biomedical.Google Scholar
McKeith, I., Perry, R., Fairbairn, A. et al (1992) Neuroleptic sensitivity with senile dementia of the Lewy body type. British Medical Journal, 305, 673–678.Google Scholar
Meyer, J., Judd, B., Tawaklna, T. et al (1986) Improved cognition after control of risk factors for multi-infarct dementia. Journal of the American Medical Association, 265, 2203–2209.Google Scholar
Meyer, J., Rogers, R., McClintic, K. et al (1989) Randomised clinical trial of daily aspirin therapy and multi-infarct dementia. Journal of the American Geriatric Society, 37, 549–555.Google Scholar
Morgan, D. G., May, P. C. & Fich, C. E. (1987) Dopamine and serotonin system in human and rodent brain, effects of age and neurodegenerative disease. Journal of the American Geriatric Society, 35, 334–345.Google Scholar
NIH Consensus Development Panel on Depression in Late Life (1992) Diagnosis and treatment of depression in late life. Journal of the American Medical Association, 268, 1018–1024.Google Scholar
OADIG (1993) How long should the elderly take antidepressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. British Journal of Psychiatry, 162, 175–182.Google Scholar
Post, F. (1966) Persistent Persecutory States of the Elderly. Oxford: Pergamon.Google Scholar
Postma, J. U. & Vranesic, D. (1985) Moclobemide in the treatment of depression in demented geriatric patients. Acta Therapeutica, 11, 1–4.Google Scholar
Reiffler, B. V., Teri, L., Raskind, M. et al (1989) Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. American Journal of Psychiatry, 146, 45–49.Google Scholar
Reynolds, C. F., Schneider, L. S., Lebowitz, B. D. et al (1993) Treatment of depression in the elderly, guidelines for primary care. In Diagnosis and Treatment of Depression in the Elderly, Proceedings of the NIH Consensus Development Panel Conference (eds Schneider, L. S., Reynolds, C. F., Lebowitz, B. & Friedhoff, A.) Washington, DC: APA.Google Scholar
SALT Collaborative Group (1991) Swedish Aspirin Low Dose Trial of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet, 338, 1345–1349.Google Scholar
Schneider, L., Pollock, D. & Lyness, S. (1990) A meta-analysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatric Society, 38, 553–563 Google Scholar
Schneider, L. & Sobin, P. (1994) Treatment for psychiatric symptoms and behavioural disturbances. In Dementia (eds Burns, A. & Levy, R.) London: Chapman and Hall.Google Scholar
Schwartz, M., Moquillansky, L., Lanyi, G. et al (1990) Sulpiride in tardive dyskinesia. Journal of Neurology, Neurosurgery and Psychiatry, 53, 800–802.Google Scholar
Seth, R., Jennings, A. L., Bindman, J. et al (1992) Combination treatment with noradrenaline and serotonin reuptake inhibitors in resistant depression. British Journal of Psychiatry, 161, 562–565.Google Scholar
Shulman, K., Tohen, M. & Satlin, A. (1992) The significance of mania in old age. Reviews in Clinical Gerontology, 2, 39–43.Google Scholar
Song, F., Freemantle, N., Sheldon, T. A. et al (1993) Selective serotonin reuptake inhibitors, a meta-analysis of efficacy and acceptability. British Medical Journal, 306, 683–687.CrossRefGoogle ScholarPubMed
Van Marwijk, H. W. J., Beeker, F. M., Nolan, W. A. et al (1990) Lithium augmentation in geriatric depression. Journal of Affective Disorders, 20, 217–223.Google Scholar
Whalley, J. L. (1989) Drug treatments of dementia. British Journal of Psychiatry, 155, 595–611.CrossRefGoogle ScholarPubMed
World Health Organization (1990) Heads of centres collaborating in WHO co-ordinated studies in biological aspects of mental illness. Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment, a consensus statement. British Journal of Psychiatry, 156, 412.Google Scholar
World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.